5-methyl-6-phenyl-4,5-dihydro-2H-pyridazin-3-one derivative
US10611731B2 · kind B2 · utility
0Cited by
1References
58Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2017 |
| Grant date | Apr 7, 2020 |
| Priority date | — |
| Expiry date | Mar 2, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D237/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides an agent for treating malignant tumor, comprising a compound of formula (1):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.